Literature DB >> 9371235

Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.

C Biot1, G Glorian, L A Maciejewski, J S Brocard.   

Abstract

The antimalarial activities of ferrocenic compounds mimicking chloroquine and active upon chloroquine-resistant strains of Plasmodium falciparum were evaluated. Four 7-chloro-4-[[[2-[(N,N-substituted amino)methyl]ferrocenyl]methyl]amino]quinoline derivatives have been synthesized; one of them, 1a, showed high potent antimalarial activity in vivo on mice infected with Plasmodium berghei N. and Plasmodium yoelii NS. and was 22 times more potent against schizontocides than chloroquine in vitro against a drug-resistant strain of P. falciparum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371235     DOI: 10.1021/jm970401y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  42 in total

1.  Lipophilic mediated assays for beta-hematin inhibitors.

Authors:  Melissa D Carter; Vanessa V Phelan; Rebecca D Sandlin; Brian O Bachmann; David W Wright
Journal:  Comb Chem High Throughput Screen       Date:  2010-03       Impact factor: 1.339

Review 2.  Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics.

Authors:  Robert L Summers; Megan N Nash; Rowena E Martin
Journal:  Cell Mol Life Sci       Date:  2012-06       Impact factor: 9.261

3.  Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.

Authors:  Jutta Marfurt; Ferryanto Chalfein; Pak Prayoga; Frans Wabiser; Enny Kenangalem; Kim A Piera; Barbara Machunter; Emiliana Tjitra; Nicholas M Anstey; Ric N Price
Journal:  Antimicrob Agents Chemother       Date:  2011-07-05       Impact factor: 5.191

4.  Ruthenium(II) arene complexes with chelating chloroquine analogue ligands: synthesis, characterization and in vitro antimalarial activity.

Authors:  Lotta Glans; Andreas Ehnbom; Carmen de Kock; Alberto Martínez; Jesús Estrada; Peter J Smith; Matti Haukka; Roberto A Sánchez-Delgado; Ebbe Nordlander
Journal:  Dalton Trans       Date:  2012-01-17       Impact factor: 4.390

5.  Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections.

Authors:  Christian Supan; Ghyslain Mombo-Ngoma; Matthias P Dal-Bianco; Carmen L Ospina Salazar; Saadou Issifou; Florent Mazuir; Aziz Filali-Ansary; Christophe Biot; Daniel Ter-Minassian; Michael Ramharter; Peter G Kremsner; Bertrand Lell
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

6.  Half-sandwich ruthenium–arene complexes with thiosemicarbazones: synthesis and biological evaluation of [(η⁶-p-cymene)Ru(piperonal thiosemicarbazones)Cl]Cl complexes.

Authors:  Floyd Beckford; Deidra Dourth; Michael Shaloski; Jacob Didion; Jeffrey Thessing; Jason Woods; Vernon Crowell; Nikolay Gerasimchuk; Antonio Gonzalez-Sarrías; Navindra P Seeram
Journal:  J Inorg Biochem       Date:  2011-08       Impact factor: 4.155

7.  Novel 4-aminoquinoline-pyrimidine based hybrids with improved in vitro and in vivo antimalarial activity.

Authors:  Sunny Manohar; U Chinna Rajesh; Shabana I Khan; Babu L Tekwani; Diwan S Rawat
Journal:  ACS Med Chem Lett       Date:  2012-06-10       Impact factor: 4.345

8.  The mechanism of antimalarial action of [Au(CQ)(PPh(3))]PF(6): structural effects and increased drug lipophilicity enhance heme aggregation inhibition at lipid/water interfaces.

Authors:  Maribel Navarro; William Castro; Alberto Martínez; Roberto A Sánchez Delgado
Journal:  J Inorg Biochem       Date:  2010-11-13       Impact factor: 4.155

9.  New medicines for malaria.

Authors:  Benjamin Mordmüller
Journal:  Wien Klin Wochenschr       Date:  2010-03       Impact factor: 1.704

10.  The antimalarial activity of Ru-chloroquine complexes against resistant Plasmodium falciparum is related to lipophilicity, basicity, and heme aggregation inhibition ability near water/n-octanol interfaces.

Authors:  Alberto Martínez; Chandima S K Rajapakse; Dalanda Jalloh; Cula Dautriche; Roberto A Sánchez-Delgado
Journal:  J Biol Inorg Chem       Date:  2009-04-03       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.